Click here to create your personal news page. The news that appears on Ovarian Cancer will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Casio Exilim Zoom EX-Z150
  2. 2. Microsoft SideWinder X6 Keyboard
  3. 3. Kodak EasyShare Z1015 IS
  4. 4. OCZ Alchemy Elixir
  5. 5. Zotac GeForce 8100
  6. 6. Samsung SC-MX20
  7. 7. Maxell VRSP-4000
  8. go to Shopping

Participate



Ovarian Cancer


Sort by : relevance - date - popularity
+Vote!

TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer

Team silences protein with siRNA, implicates TG2 in fourth cancer

+Vote!

Got 5 minutes?

(Bracelet made by Lisa for Ovarian Cancer awareness. Photo by Tug.) I'm sure you all remember Lisa . A lot of you said prayers, sent good thoughts, joined in the raffle to help send her and her family to DisneyWorld. Here's a paragraph from her post today: My doctor STOPPED treatment today. I didn’t have chemotherapy today because it isn’t working. My CT scan showed that the tumors in my lungs and...

+Vote!

MediGene Exercises Option for DKFZ's Monoclonal Antibody

MediGene has announced that it will exercise the option granted by the German Cancer Research Center in Heidelberg for the development and commercialization of an antibody for the treatment of different types of cancer, including ovarian cancer.

+Vote!

Analgesic drugs don't reduce ovarian cancer risk

NEW YORK (Reuters Health) - The regular use of over-the-counter analgesic drugs, such as aspirin and ibuprofen, does not appear to reduce the risk of ovarian cancer, according to findings published in the American Journal of Epidemiology.

+Vote!
+Vote!

Callaway Golf Foundation and the Entertainment Industry Foundation Launch Public Service Campaign with Halle Berry to Raise Awareness for Ovarian Cancer

CARLSBAD, Calif. - Academy Award-winning actress Halle Berry has joined forces with the Callaway Golf Foundation and the Entertainment Industry Foundation as the 2008 ambassador for the Callaway Golf Foundation Women’s Cancer Initiative. Berry will be feature

+Vote!

TG2 Identified As Potential Therapeutic Target In Chemo-Resistant Ovarian Cancer

M. D. Anderson team silences protein with siRNA, implicates TG2 in fourth cancer Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates.

+Vote!

Halle Berry Gives Back!

New mom Halle Berry is giving back! The Oscar winner is challenging the public to join the Callaway Golf Foundation and the Entertainment Industry Foundation in the fight to find a cure for ovarian cancer -- and ET has a first look at her new ad! Halle is appearing in a print public service announcement campaign this summer to raise awareness and funding for the cancer that strikes more than 22,000...

+Vote!

Abeome and Cato Research to Collaborate on Ovarian Cancer Drug

Abeome has announced a strategic equity investment by Cato BioVentures and collaboration with Cato Research, its global contract R&D organization. The investment and collaboration will help support continued development of Abeome's lead ovarian cancer project.

+Vote!

Stephanie’s Angels Promote Ovarian Cancer Awareness and Research

Keisha Sapp and her close friends created Stephanie’s Angels Ovarian Cancer Awareness Day on Saturday, July 12, which had cancer awareness in a variety of locations in Northern New Jersey....

+Vote!

TG2 Identified as Potential Target in Chemo-Resistant Ovarian Cancer

Team silences protein with siRNA, implicates TG2 in fourth cancer

1Vote!

TG2 Identified as Potential Target in Chemo-Resistant Ovarian Cancer

Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide...

+Vote!

TG2 Identified As Potential Therapeutic Target In Chemo-resistant Ovarian Cancer

Researchers connect overexpression of tissue type transglutaminase with poor prognosis in ovarian cancer, identify the relevant pathway, and shut TG2 down with an siRNA liposomal nanoparticle. They previously pinpointed TG2's role in resistant and metastatic melanoma and breast and pancreatic cancers. This crucial protein fuels different cancers through different pathways.

1Vote!

Friends of mom who died of ovarian cancer inform others about disease

When health-conscious Newark mom Stephanie Wilkins died in April of ovarian cancer at age 49, her friends were shocked. To help prevent other women from falling victim to the same disease -- the most deadly of all gynecological cancers, according...

+Vote!

Ramsey family cleared in JonBenet case

Filed under: In the news The news came along to late for mother Patsy Ramsey, who died of ovarian cancer in 2006. But new DNA technology has proved that there was an "unexplained third party" who was involved in the murder of JonBenet Ramsey, essentially clearing her family of any wrong doing. In the 12 years since JonBenet was found in the basement of her home, her family has been under a cloud of...

The last article published by a user on Ovarian Cancer :

3Vote!

Stakeholder Opinions: Ovarian Cancer - Growing importance as secondary indication for targeted therapies

Stakeholder Opinions: Ovarian Cancer - Growing importance as secondary indication for targeted therapies Introduction Despite being the most common cause of death from gynecological tumors, ovarian cancer has not traditionally attracted the same level of R&D interest as other female cancers. Nevertheless, nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year is,...